Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127034473 | 12703447 | 3 | F | 20120720 | 20160912 | 20160831 | 20160923 | EXP | US-PFIZER INC-2016404579 | PFIZER | ADAY, A.. PREVENTION AS PRECIPITANT. NEW ENGLAND JOURNAL OF MEDICINE. 2016;375 (5):471-475 | 72.00 | YR | M | Y | 0.00000 | 20160923 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127034473 | 12703447 | 1 | PS | CEFAZOLIN | CEFAZOLIN | 1 | UNK | Y | 65226 | ||||||||||
| 127034473 | 12703447 | 2 | C | RIVAROXABAN | RIVAROXABAN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127034473 | 12703447 | 1 | Prophylaxis |
| 127034473 | 12703447 | 2 | Deep vein thrombosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127034473 | 12703447 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127034473 | 12703447 | Acute generalised exanthematous pustulosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127034473 | 12703447 | 1 | 20120718 | 0 |